136 related articles for article (PubMed ID: 25168481)
1. Dsh homolog DVL3 mediates resistance to IGFIR inhibition by regulating IGF-RAS signaling.
Gao S; Bajrami I; Verrill C; Kigozi A; Ouaret D; Aleksic T; Asher R; Han C; Allen P; Bailey D; Feller S; Kashima T; Athanasou N; Blay JY; Schmitz S; Machiels JP; Upile N; Jones TM; Thalmann G; Ashraf SQ; Wilding JL; Bodmer WF; Middleton MR; Ashworth A; Lord CJ; Macaulay VM
Cancer Res; 2014 Oct; 74(20):5866-77. PubMed ID: 25168481
[TBL] [Abstract][Full Text] [Related]
2. Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins.
Guix M; Faber AC; Wang SE; Olivares MG; Song Y; Qu S; Rinehart C; Seidel B; Yee D; Arteaga CL; Engelman JA
J Clin Invest; 2008 Jul; 118(7):2609-19. PubMed ID: 18568074
[TBL] [Abstract][Full Text] [Related]
3. Cetuximab-induced insulin-like growth factor receptor I activation mediates cetuximab resistance in gastric cancer cells.
Li X; Xu L; Li H; Zhao L; Luo Y; Zhu Z; Liu Y; Qu X
Mol Med Rep; 2015 Jun; 11(6):4547-54. PubMed ID: 25625229
[TBL] [Abstract][Full Text] [Related]
4. Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors.
Buck E; Eyzaguirre A; Rosenfeld-Franklin M; Thomson S; Mulvihill M; Barr S; Brown E; O'Connor M; Yao Y; Pachter J; Miglarese M; Epstein D; Iwata KK; Haley JD; Gibson NW; Ji QS
Cancer Res; 2008 Oct; 68(20):8322-32. PubMed ID: 18922904
[TBL] [Abstract][Full Text] [Related]
5. Differential mediation of the Wnt canonical pathway by mammalian Dishevelleds-1, -2, and -3.
Lee YN; Gao Y; Wang HY
Cell Signal; 2008 Feb; 20(2):443-52. PubMed ID: 18093802
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of SHIP-mediated inhibition of insulin- and platelet-derived growth factor-stimulated mitogen-activated protein kinase activity in 3T3-L1 adipocytes.
Sharma PM; Son HS; Ugi S; Ricketts W; Olefsky JM
Mol Endocrinol; 2005 Feb; 19(2):421-30. PubMed ID: 15486046
[TBL] [Abstract][Full Text] [Related]
7. The IGF-Trap: Novel Inhibitor of Carcinoma Growth and Metastasis.
Wang N; Rayes RF; Elahi SM; Lu Y; Hancock MA; Massie B; Rowe GE; Aomari H; Hossain S; Durocher Y; Pinard M; Tabariès S; Siegel PM; Brodt P
Mol Cancer Ther; 2015 Apr; 14(4):982-93. PubMed ID: 25673819
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10.
Dey BR; Frick K; Lopaczynski W; Nissley SP; Furlanetto RW
Mol Endocrinol; 1996 Jun; 10(6):631-41. PubMed ID: 8776723
[TBL] [Abstract][Full Text] [Related]
9. Association between GRB2/Sos and insulin receptor substrate 1 is not sufficient for activation of extracellular signal-regulated kinases by interleukin-4: implications for Ras activation by insulin.
Pruett W; Yuan Y; Rose E; Batzer AG; Harada N; Skolnik EY
Mol Cell Biol; 1995 Mar; 15(3):1778-85. PubMed ID: 7862167
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways.
Sasaoka T; Ishiki M; Sawa T; Ishihara H; Takata Y; Imamura T; Usui I; Olefsky JM; Kobayashi M
Endocrinology; 1996 Oct; 137(10):4427-34. PubMed ID: 8828504
[TBL] [Abstract][Full Text] [Related]
11. Activation of the insulin-like growth factor-1 receptor induces resistance to epidermal growth factor receptor antagonism in head and neck squamous carcinoma cells.
Jameson MJ; Beckler AD; Taniguchi LE; Allak A; Vanwagner LB; Lee NG; Thomsen WC; Hubbard MA; Thomas CY
Mol Cancer Ther; 2011 Nov; 10(11):2124-34. PubMed ID: 21878657
[TBL] [Abstract][Full Text] [Related]
12. Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer.
Chan DW; Chan CY; Yam JW; Ching YP; Ng IO
Gastroenterology; 2006 Oct; 131(4):1218-27. PubMed ID: 17030191
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor and K-Ras mutations and resistance of lung cancer to insulin-like growth factor 1 receptor tyrosine kinase inhibitors.
Kim WY; Prudkin L; Feng L; Kim ES; Hennessy B; Lee JS; Lee JJ; Glisson B; Lippman SM; Wistuba II; Hong WK; Lee HY
Cancer; 2012 Aug; 118(16):3993-4003. PubMed ID: 22359227
[TBL] [Abstract][Full Text] [Related]
14. Non-SH2 domains within insulin receptor substrate-1 and SHC mediate their phosphotyrosine-dependent interaction with the NPEY motif of the insulin-like growth factor I receptor.
Craparo A; O'Neill TJ; Gustafson TA
J Biol Chem; 1995 Jun; 270(26):15639-43. PubMed ID: 7541045
[TBL] [Abstract][Full Text] [Related]
15. Type I insulin-like growth factor receptor over-expression induces proliferation and anti-apoptotic signaling in a three-dimensional culture model of breast epithelial cells.
Yanochko GM; Eckhart W
Breast Cancer Res; 2006; 8(2):R18. PubMed ID: 16584539
[TBL] [Abstract][Full Text] [Related]
16. Degradation of epidermal growth factor receptor mediates dasatinib-induced apoptosis in head and neck squamous cell carcinoma cells.
Lin YC; Wu MH; Wei TT; Chuang SH; Chen KF; Cheng AL; Chen CC
Neoplasia; 2012 Jun; 14(6):463-75. PubMed ID: 22787428
[TBL] [Abstract][Full Text] [Related]
17. AMPK activators suppress cervical cancer cell growth through inhibition of DVL3 mediated Wnt/β-catenin signaling activity.
Kwan HT; Chan DW; Cai PC; Mak CS; Yung MM; Leung TH; Wong OG; Cheung AN; Ngan HY
PLoS One; 2013; 8(1):e53597. PubMed ID: 23301094
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the insulin-like growth factor I receptor by epigallocatechin gallate blocks proliferation and induces the death of Ewing tumor cells.
Kang HG; Jenabi JM; Liu XF; Reynolds CP; Triche TJ; Sorensen PH
Mol Cancer Ther; 2010 May; 9(5):1396-407. PubMed ID: 20423994
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.
Raju U; Molkentine DP; Valdecanas DR; Deorukhkar A; Mason KA; Buchholz TA; Meyn RE; Ang KK; Skinner H
Cancer Med; 2015 Jan; 4(1):65-74. PubMed ID: 25355701
[TBL] [Abstract][Full Text] [Related]
20. Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation.
Fox EM; Kuba MG; Miller TW; Davies BR; Arteaga CL
Breast Cancer Res; 2013; 15(4):R55. PubMed ID: 23844554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
